Cellular α-synuclein fate may be determined through Arg3.1/Arc’s protein-regulatory effect on lipid raft function in neuron membranes [164]; this suggests a role of aberrant Arg3.1/Arc expression in PD progression. This evidence concerns the gene ARC and Parkinson disease.